744 related articles for article (PubMed ID: 33297481)
21. Regulatory and effector B cells: Friends or foes?
Matsushita T
J Dermatol Sci; 2019 Jan; 93(1):2-7. PubMed ID: 30514664
[TBL] [Abstract][Full Text] [Related]
22. Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.
Levesque MC
Clin Exp Immunol; 2009 Aug; 157(2):198-208. PubMed ID: 19604259
[TBL] [Abstract][Full Text] [Related]
23. Plasma cells as an innovative target in autoimmune disease with renal manifestations.
Hiepe F; Radbruch A
Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses.
Ettinger R; Karnell JL; Henault J; Panda SK; Riggs JM; Kolbeck R; Sanjuan MA
Autoimmunity; 2017 Feb; 50(1):25-36. PubMed ID: 28166684
[TBL] [Abstract][Full Text] [Related]
25. T- and B-cell abnormalities in systemic lupus erythematosus.
Nagy G; Koncz A; Perl A
Crit Rev Immunol; 2005; 25(2):123-40. PubMed ID: 15952933
[TBL] [Abstract][Full Text] [Related]
26. The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
Crofford LJ; Nyhoff LE; Sheehan JH; Kendall PL
Expert Rev Clin Immunol; 2016 Jul; 12(7):763-73. PubMed ID: 26864273
[TBL] [Abstract][Full Text] [Related]
27. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
[TBL] [Abstract][Full Text] [Related]
28. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
[TBL] [Abstract][Full Text] [Related]
29. Innate immunity as the trigger of systemic autoimmune diseases.
Saferding V; Blüml S
J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.
De Groof A; Hémon P; Mignen O; Pers JO; Wakeland EK; Renaudineau Y; Lauwerys BR
Clin Rev Allergy Immunol; 2017 Oct; 53(2):181-197. PubMed ID: 28500565
[TBL] [Abstract][Full Text] [Related]
31. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
32. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
33. Anticytokine therapy impacting on B cells in autoimmune diseases.
Daridon C; Burmester GR; Dörner T
Curr Opin Rheumatol; 2009 May; 21(3):205-10. PubMed ID: 19346949
[TBL] [Abstract][Full Text] [Related]
34. Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.
Morawski PA; Bolland S
Trends Immunol; 2017 May; 38(5):373-382. PubMed ID: 28274696
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
Alexander T; Cheng Q; Klotsche J; Khodadadi L; Waka A; Biesen R; Hoyer BF; Burmester GR; Radbruch A; Hiepe F
Eur J Immunol; 2018 Sep; 48(9):1573-1579. PubMed ID: 29979809
[TBL] [Abstract][Full Text] [Related]
36. [New therapeutic approaches to autoimmune diseases].
Amoura Z; Piette JC
Presse Med; 2006 Apr; 35(4 Pt 2):709-13. PubMed ID: 16614619
[TBL] [Abstract][Full Text] [Related]
37. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.
Cancro MP; D'Cruz DP; Khamashta MA
J Clin Invest; 2009 May; 119(5):1066-73. PubMed ID: 19411764
[TBL] [Abstract][Full Text] [Related]
38. Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects.
Soni C; Reizis B
Front Immunol; 2019; 10():1601. PubMed ID: 31354738
[TBL] [Abstract][Full Text] [Related]
39. Dysfunctional B cells in systemic lupus erythematosus.
Renaudineau Y; Pers JO; Bendaoud B; Jamin C; Youinou P
Autoimmun Rev; 2004 Nov; 3(7-8):516-23. PubMed ID: 15546800
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance and immunobiology of IL-21 in autoimmunity.
Long D; Chen Y; Wu H; Zhao M; Lu Q
J Autoimmun; 2019 May; 99():1-14. PubMed ID: 30773373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
